This website uses cookies to ensure you get the best experience on our website.
- Table of Contents
Real validated DNAJA1 Western blot protocols, expected-band and isoform facts, troubleshooting for weak or shifted signal, and recommended anti-DNAJA1 WB antibodies. Everything you need to plan the experiment before you commit precious samples.
Expected bands, validated protocols, controls and antibodies — the at-a-glance facts below, then the full design guide.
| Expected band | ~44.9 kDa | |
| Gel | 12–15% (standard starting point) | |
| Positive control | Appendix (IHC candidate; verify WB) +4 more | |
| Negative control | Adipose tissue (IHC candidate; verify WB) |
| PTM | Phosphorylated + Acetylated | |
| Caveat | Modification-state controls | |
| Gene-set association | MSigDB Hallmark membership | |
| Isoform | 2 isoform(s) |
The M04151 protocol combines labelled catalog values with standard starting conditions. Published comparisons retain their own sample, reagent and detection scope.
| Sample / lysate | Jurkat cell lysate (catalog M04151) |
| Gel % | 12–15% (standard starting point) |
| Load | 20–30 µg total protein per lane; optimize for abundance (standard starting point) |
| Transfer | Standard semi-dry transfer; verify efficiency (standard starting point) |
| Membrane | 0.45 µm PVDF (standard starting point) |
| Blocking | 5% milk or 5% BSA in TBST (standard starting point) |
| Primary antibody | M04151; use the WB datasheet starting dilution (standard starting point) |
| Primary incubation | Overnight at 4 °C (standard starting point) |
| Secondary antibody | Species-matched HRP conjugate at validated dilution (standard starting point) |
| Secondary incubation | 1 h at room temperature (standard starting point) |
| Wash | 3 × 5 min in TBST (standard starting point) |
| Detection | ECL; bracket exposures to avoid saturation (standard starting point) |
DNAJA1 has a predicted precursor mass of 44.9 kDa; propeptide cleavage and isoforms could affect size, but their migration and an empirical band are unreported.
| Band near 44.9 kDa | Consistent with the predicted DNAJA1 precursor; confirm its identity with a specific control. |
| Band slightly below 44.9 kDa | Could reflect removal of the three-residue propeptide at 395–397. |
| Bands at different sizes | Could reflect isoforms 1 and 2; distinct migration has not been established. |
| Weak band in a soluble fraction | Could reflect DNAJA1 association with membranes through a lipid anchor. |
| Predicted precursor mass | Sets a reference near 44.9 kDa, not a measured Western blot position. |
| Propeptide at residues 395–397 | Its removal could make mature DNAJA1 slightly smaller than the precursor. |
| Splice isoform 1 | Its size relative to isoform 2 is not supplied. |
| Splice isoform 2 | It could migrate differently from isoform 1, but the direction and separation are unknown. |
| Situation | Likely cause | Next action |
|---|---|---|
| No band in lysate | Membrane-associated DNAJA1 may be poorly extracted. | Check extraction and compare soluble and membrane fractions. |
| Band higher than expected | The band may represent modified DNAJA1 or an unrelated protein; a visible shift is unproven. | Check identity with DNAJA1 knockdown and a second antibody. |
| Band lower than expected | Propeptide removal or an isoform is possible; neither has a supplied band size. | Check band identity with DNAJA1 knockdown. |
| Multiple bands | Isoforms 1 and 2 are reported, but their separation on a blot is unknown. | Check which bands decrease after DNAJA1 knockdown. |
| Weak or no signal | DNAJA1 may be underrepresented after fractionation because it associates with membranes. | Compare membrane and soluble fractions and check loading. |
Comprehensive Human Protein Atlas IHC scoring per tissue. Rows are taken directly from the HPA tissue chart — click any row's HPA link to view the source.
| Tissue | Cell type | Level | Evidence | Source |
|---|---|---|---|---|
| Appendix | glandular cells | High | Protein (IHC) | HPA → |
| Bone marrow | hematopoietic cells | High | Protein (IHC) | HPA → |
| Breast | glandular cells | High | Protein (IHC) | HPA → |
| Caudate | neuronal cells | High | Protein (IHC) | HPA → |
| Cerebral cortex | glial cells | High | Protein (IHC) | HPA → |
| Tissue | Cell type | Level | Evidence | Source |
|---|---|---|---|---|
| Adipose tissue | adipocytes | Not detected | Protein (IHC) | HPA → |
| Heart muscle | cardiomyocytes | Not detected | Protein (IHC) | HPA → |
| Liver | cholangiocytes | Not detected | Protein (IHC) | HPA → |
| Parathyroid gland | glandular cells | Not detected | Protein (IHC) | HPA → |
| Smooth muscle | smooth muscle cells | Low | Protein (IHC) | HPA → |
Deeper troubleshooting and optimisation questions for DNAJA1, answered from its protein features.
Catalog antibodies with Western blot application and product-specific WB images. Evaluate suitability with the reported sample, controls and experimental conditions.
Both catalogued anti-DNAJA1 antibodies list human, mouse, and rat reactivity and have Western blot images. M04151 is shown with Jurkat lysate; PA1597 is shown with rat and mouse tissues and several cell lines. No publication evidence is supplied.
Which to pick: Choose M04151 if the shown Jurkat lysate matches your context. Choose PA1597 if its documented rat or mouse brain and lung tissues, or listed cell-line lysates, better match your sample. Both list the same species reactivity; the images show specific tested samples.